AUG 17, 2016 06:43 AM PDT

Magnetic Bacteria Ferry Chemo Drugs to Resistant Tumors

WRITTEN BY: Xuan Pham
By combining nanotechnology and the wonderful world of microbiology, Canadian scientists have created something truly unique in the field of cancer medicine. Specifically, they leveraged the power of magnetotactic bacteria to create nanorobots that deliver chemotherapy agents directly into the tumor, even into the hardest to treat areas.
 
Legions of nanorobots target cancerous tumors with precision | Image: The NanoRobotics Laboratory, Polytechnique Montréal
"These legions of nanorobotic agents were actually composed of more than 100 million flagellated bacteria - and therefore self-propelled - and loaded with drugs that moved by taking the most direct path between the drug's injection point and the area of the body to cure," said Sylvain Martel, Director of the Polytechnique Montréal Nanorobotics Laboratory, and senior study author.
 
The technology sounds like science fiction come-to-life. The microbes behind this so-called legions of nanorobots are magnetotactic bacteria (Magnetococcus marinus strain MC-1). Discovered by Richard P. Blakemore in 1975, magnetotactic bacteria are tiny microorganisms that have the capacity to convert iron into magenetite inside organelles called magnetosomes. Each of the magnetite crystal acts as a nano-magnet, and a chain of these act as a built-in compass for north and south detection. The bacteria use these internal compasses to move and align themselves in watery regions with optimal oxygen concentrations.
 

Martel and his team exploited the unique characteristics of the magnetotactic bacteria to ferry drug-loaded lipososomes into tumors. In particular, M. marinus has a penchant for regions of low oxygen concentration. This makes them ideal carriers of chemotherapy drugs to tumors, since many contain hypoxic regions that are often resistant to therapies.
 
In mice experiments, Martel and his team showed the nanorobots could deliver drugs in a targeted fashion to colorectal tumors. "The drug's propelling force was enough to travel efficiently and enter deep inside the tumors,” he added.
 
The concept of using the bacteria-propelled nanorobots to control and target drug release could potentially minimize the chemotherapy-related collateral damages to the healthy cells. Furthermore, because of higher precision to the tumor, doctors may be able to use a lower dose of the drug to achieve the same potency. This would also curtail side-effects of chemotherapy.
 
“This innovative use of nanotransporters will have an impact not only on creating more advanced engineering concepts and original intervention methods, but it also throws the door wide open to the synthesis of new vehicles for therapeutic, imaging and diagnostic agents," said Martel. "Chemotherapy, which is so toxic for the entire human body, could make use of these natural nanorobots to move drugs directly to the targeted area, eliminating the harmful side effects while also boosting its therapeutic effectiveness."

Additional sources: Polytechnique Montréal press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 14, 2019
Cancer
OCT 14, 2019
Understanding osteosarcoma in kids and dogs
New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Aspirin Usage Improves Liver Function After Embolization Treatment
Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving ...
OCT 14, 2019
Cancer
OCT 14, 2019
Antibiotic use associated with bowel cancer
From 2000–2010, global consumption of antibiotics rose by 35% up to 70 billion doses each year. Although doctors are more cautious to prescribe antib...
OCT 14, 2019
Immunology
OCT 14, 2019
New Observations of a Cancer Transcriptase
New research shows a transcriptase that helps time cell death varies in expression, and is unusually localized, in cancer cells.  The transcriptase, T...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
OCT 14, 2019
Cardiology
OCT 14, 2019
What is Polycythemia Vera?
Polycythemia Vera (PV) is a slow-growing cancer of the blood. The cancer is characterized by an overproduction of blood cells within the bone marrow. Too m...
Loading Comments...